Why Should I Vote On BetterDistricts?

Polling is a powerful tool to help our elected officials determine how they should vote.

Standard polling methods don't give you the control that you deserve. With BetterDistricts you can show your representative exactly how strongly a bill is supported in your community.

Send a clear signal on how you want your government to work.

 

H.R. 4275 - Empowering Pharmacists in the Fight Against Opioid Abuse Act

Introduced: 2018-06-13
Bill Status: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
 

Empowering Pharmacists in the Fight Against Opioid Abuse Act

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

HHS must seek input from relevant stakeholders.

Full Text


115th CONGRESS
2d Session
H. R. 4275


IN THE SENATE OF THE UNITED STATES

June 13, 2018

    Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions


AN ACT

    To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on indicators that a prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Empowering Pharmacists in the Fight Against Opioid Abuse Act”.

SEC. 2. Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription.

(a) In general.—Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, the Commissioner of Food and Drugs, the Director of the Centers for Disease Control and Prevention, and the Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate programs and materials for training pharmacists, health care providers, and patients on—

(1) circumstances under which a pharmacist may, consistent with section 201 of the Controlled Substances Act (21 U.S.C. 811) and regulations thereunder, including section 1306.04 of title 21, Code of Federal Regulations, decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion; and

(2) any Federal requirements pertaining to declining to fill a prescription under such cir­cum­stances.

(b) Materials included.—In developing materials under subsection (a), the Secretary of Health and Human Services shall include information educating—

(1) pharmacists on how to decline to fill a prescription and actions to take after declining to fill a prescription; and

(2) other health care practitioners and the public on a pharmacist’s responsibility to decline to fill prescriptions in certain circumstances.

(c) Stakeholder input.—In developing the programs and materials required under subsection (a), the Secretary of Health and Human Services shall seek input from relevant national, State, and local associations, boards of pharmacy, medical societies, licensing boards, health care practitioners, and patients.

Passed the House of Representatives June 12, 2018.

    Attest:karen l. haas,   
    Clerk.

Relevant News Stories And Blog Posts

Title Worth Reading

Vote on H.R. 4275

 

Activity in last 30 days